Atlas Trials

Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT

Clinical trial NCT06061848 · RECRUITING

Trial details

NCT number
NCT06061848
Sponsor
Lars Olaf Cardell
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Allergic Rhinitis Due to Grass Pollen
Start date
2023-02-01
Primary completion
2030-12-28
Enrollment
360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.